Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Primary Care|January 26, 2024
Novel Pharmacotherapies for HyperlipidemiaBrian V Reamy, Brian Ford, Charles GoodmanOptics Express|June 3, 2009
Real-time Raman spectroscopy of optically trapped living cells and organellesChangan Xie, Charles Goodman, Mumtaz Dinno, et al.Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacyAndrew Hiatt, Natasha Bohorova, Ognian Bohorov, et al.Clinical and Vaccine Immunology : CVI|February 28, 2014
Chimeric plantibody passively protects mice against aerosolized ricin challengeErin K Sully, Kevin J Whaley, Natasha Bohorova, et al.Toxicon : Official Journal of the International Society on Toxinology|September 28, 2014
A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxinErin K Sully, Kevin Whaley, Natasha Bohorova, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Origin and Correlates of Viral Rebound in SIV-Infected Rhesus Macaques Following ART DiscontinuationIrena King, Malika Aid, Emek Kose, et al.Science Translational Medicine|April 7, 2017
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibodyChad E Mire, Joan B Geisbert, Viktoriya Borisevich, et al.Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Monoclonal antibody therapy for Junin virus infectionLarry Zeitlin, Joan B Geisbert, Daniel J Deer, et al.Nature|August 30, 2014
Reversion of advanced Ebola virus disease in nonhuman primates with ZMappXiangguo Qiu, Gary Wong, Jonathan Audet, et al.Research Square|July 17, 2025
Identification of initial sites of SIV rebound after treatment cessationLouis Picker, Brandon Keele, Afam Okoye, et al.Pageof 2